RxDoctor Payments Data

Ighovwerha Ofotokun, MD

Infectious Disease · Atlanta, GANPI 1104918556

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,760 of the $2,760 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Viiv Healthcare Company.

$2,760in general payments, 2019–2025

Across 1 payment — averaging $2760.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$3K
$207,143in research payments, 2019–2025

Across 6 payments — averaging $34,524 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$207K

What the payments were for

  • Consulting fees$2,760100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viiv Healthcare Company1$2,760

How this compares

$2,760 in reported general payments places this provider in the 65th percentile of 260 infectious disease providers in Georgia.

See all infectious disease providers in Georgia

Medicare billing

Part B allowed, 2024
$3,065
Medicare patients
14
Services billed
29

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →